Pneumococcal Vaccines Market to Surpass US$ 13,194.3 Million by 2026
Pharmaceutical companies are reluctant to invest in production of new vaccines, owing to very less returns.
Pharmaceutical companies are reluctant to invest in production of new vaccines, owing to very less returns.
